Literature DB >> 28337550

Common genetic etiology between "multiple sclerosis-like" single-gene disorders and familial multiple sclerosis.

Anthony L Traboulsee1, A Dessa Sadovnick1,2, Mary Encarnacion2, Cecily Q Bernales2, Irene M Yee2, Maria G Criscuoli2, Carles Vilariño-Güell3.   

Abstract

Several single-gene disorders with clinical and radiological characteristics similar to those observed in multiple sclerosis (MS) patients have been described. To evaluate whether this phenotypic overlap can be ascribed to a common genetic etiology, 28 genes known to present pathogenic mutations for 24 of these disorders were sequenced in 270 MS patients. All identified variants were genotyped in 2131 MS cases and 830 healthy controls, and those exclusively observed in patients were assessed for segregation within families. This analysis identified 9 rare variants in 6 genes segregating with disease in 13 families. Four different mutations were identified in CYP27A1, including a reported pathogenic mutation for cerebrotendinous xanthomatosis (p.R405W), which was observed in six patients from a multi-incident family, three diagnosed with MS, two with an undefined neurological disease and one seemingly healthy. A LYST p.V1678A and a PDHA1 p.K387Q mutation were both observed in five MS patients from three separate multi-incident families. In addition, CLCN2 p.V174G, GALC p.D162E and POLG p.R361G were each identified in two MS patients from one family. This study suggests a shared genetic etiology between MS and the characterized single-gene disorders, and highlights cholesterol metabolism and the synthesis of oxysterols as important biological mechanisms for familial MS.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28337550     DOI: 10.1007/s00439-017-1784-9

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  47 in total

Review 1.  Environmental factors and multiple sclerosis.

Authors:  George C Ebers
Journal:  Lancet Neurol       Date:  2008-03       Impact factor: 44.182

Review 2.  Familial recurrence risks and inheritance of multiple sclerosis.

Authors:  A D Sadovnick
Journal:  Curr Opin Neurol Neurosurg       Date:  1993-04

3.  Oxysterols regulate encephalitogenic CD4(+) T cell trafficking during central nervous system autoimmunity.

Authors:  F Chalmin; V Rochemont; C Lippens; A Clottu; A W Sailer; D Merkler; S Hugues; C Pot
Journal:  J Autoimmun       Date:  2014-11-10       Impact factor: 7.094

Review 4.  The spectrum of pyruvate oxidation defects in the diagnosis of mitochondrial disorders.

Authors:  Wolfgang Sperl; Leanne Fleuren; Peter Freisinger; Tobias B Haack; Antonia Ribes; René G Feichtinger; Richard J Rodenburg; Franz A Zimmermann; Johannes Koch; Isabel Rivera; Holger Prokisch; Jan A Smeitink; Johannes A Mayr
Journal:  J Inherit Metab Dis       Date:  2014-12-20       Impact factor: 4.982

Review 5.  Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes.

Authors:  Simon Zhornitsky; Kyla A McKay; Luanne M Metz; Charlotte E Teunissen; Manu Rangachari
Journal:  Mult Scler Relat Disord       Date:  2015-10-19       Impact factor: 4.339

6.  Frontal lobe dementia with abnormal cholesterol metabolism and heterozygous mutation in sterol 27-hydroxylase gene (CYP27).

Authors:  S Sugama; A Kimura; W Chen; S Kubota; Y Seyama; N Taira; Y Eto
Journal:  J Inherit Metab Dis       Date:  2001-06       Impact factor: 4.982

7.  Case-Control Studies Are Not Familial Studies.

Authors:  Zhe Wang; A Dessa Sadovnick; Anthony L Traboulsee; Jay P Ross; Cecily Q Bernales; Mary Encarnacion; Irene M Yee; Madonna de Lemos; Talitha Greenwood; Joshua D Lee; Galen Wright; Colin J Ross; Si Zhang; Weihong Song; Carles Vilariño-Güell
Journal:  Neuron       Date:  2016-10-19       Impact factor: 17.173

8.  Association of alpha-, beta-, and gamma-Synuclein with diffuse lewy body disease.

Authors:  Kenya Nishioka; Christian Wider; Carles Vilariño-Güell; Alexandra I Soto-Ortolaza; Sarah J Lincoln; Jennifer M Kachergus; Barbara Jasinska-Myga; Owen A Ross; Alex Rajput; Christopher A Robinson; Tanis J Ferman; Zbigniew K Wszolek; Dennis W Dickson; Matthew J Farrer
Journal:  Arch Neurol       Date:  2010-08

9.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

10.  Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients.

Authors:  A Dessa Sadovnick; Anthony L Traboulsee; Cecily Q Bernales; Jay P Ross; Amanda L Forwell; Irene M Yee; Lena Guillot-Noel; Bertrand Fontaine; Isabelle Cournu-Rebeix; Antonio Alcina; Maria Fedetz; Guillermo Izquierdo; Fuencisla Matesanz; Kelly Hilven; Bénédicte Dubois; An Goris; Ianire Astobiza; Iraide Alloza; Alfredo Antigüedad; Koen Vandenbroeck; Denis A Akkad; Orhan Aktas; Paul Blaschke; Mathias Buttmann; Andrew Chan; Joerg T Epplen; Lisa-Ann Gerdes; Antje Kroner; Christian Kubisch; Tania Kümpfel; Peter Lohse; Peter Rieckmann; Uwe K Zettl; Frauke Zipp; Lars Bertram; Christina M Lill; Oscar Fernandez; Patricia Urbaneja; Laura Leyva; Jose Carlos Alvarez-Cermeño; Rafael Arroyo; Aroa M Garagorri; Angel García-Martínez; Luisa M Villar; Elena Urcelay; Sunny Malhotra; Xavier Montalban; Manuel Comabella; Thomas Berger; Franz Fazekas; Markus Reindl; Mascha C Schmied; Alexander Zimprich; Carles Vilariño-Güell
Journal:  G3 (Bethesda)       Date:  2016-07-07       Impact factor: 3.154

View more
  6 in total

1.  Analysis of NOD-like receptor NLRP1 in multiple sclerosis families.

Authors:  Cecily Q Bernales; Mary Encarnacion; Maria G Criscuoli; Irene M Yee; Anthony L Traboulsee; A Dessa Sadovnick; Carles Vilariño-Güell
Journal:  Immunogenetics       Date:  2017-10-07       Impact factor: 2.846

2.  Exonic variants of genes related to the vitamin D signaling pathway in the families of familial multiple sclerosis using whole-exome next generation sequencing.

Authors:  Vanesa Pytel; Jordi A Matías-Guiu; Laura Torre-Fuentes; Paloma Montero-Escribano; Paolo Maietta; Javier Botet; Sara Álvarez; Ulises Gómez-Pinedo; Jorge Matías-Guiu
Journal:  Brain Behav       Date:  2019-03-21       Impact factor: 2.708

3.  Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease.

Authors:  Carles Vilariño-Güell; Alexander Zimprich; Filippo Martinelli-Boneschi; Bruno Herculano; Zhe Wang; Fuencisla Matesanz; Elena Urcelay; Koen Vandenbroeck; Laura Leyva; Denis Gris; Charbel Massaad; Jacqueline A Quandt; Anthony L Traboulsee; Mary Encarnacion; Cecily Q Bernales; Jordan Follett; Irene M Yee; Maria G Criscuoli; Angela Deutschländer; Eva M Reinthaler; Tobias Zrzavy; Elisabetta Mascia; Andrea Zauli; Federica Esposito; Antonio Alcina; Guillermo Izquierdo; Laura Espino-Paisán; Jorge Mena; Alfredo Antigüedad; Patricia Urbaneja-Romero; Jesús Ortega-Pinazo; Weihong Song; A Dessa Sadovnick
Journal:  PLoS Genet       Date:  2019-06-06       Impact factor: 5.917

4.  Quantitative proteomics reveals protein dysregulation during T cell activation in multiple sclerosis patients compared to healthy controls.

Authors:  Chiara Cappelletti; Anna Eriksson; Ina Skaara Brorson; Ingvild S Leikfoss; Oda Kråbøl; Einar August Høgestøl; Valeria Vitelli; Olav Mjaavatten; Hanne F Harbo; Frode Berven; Steffan D Bos; Tone Berge
Journal:  Clin Proteomics       Date:  2022-07-05       Impact factor: 5.000

5.  NLRX1 inhibits the early stages of CNS inflammation and prevents the onset of spontaneous autoimmunity.

Authors:  Marjan Gharagozloo; Shaimaa Mahmoud; Camille Simard; Kenzo Yamamoto; Diwakar Bobbala; Subburaj Ilangumaran; Matthew D Smith; Albert Lamontagne; Samir Jarjoura; Jean-Bernard Denault; Véronique Blais; Louis Gendron; Carles Vilariño-Güell; A Dessa Sadovnick; Jenny P Ting; Peter A Calabresi; Abdelaziz Amrani; Denis Gris
Journal:  PLoS Biol       Date:  2019-09-16       Impact factor: 8.029

6.  Multiple Sclerosis as a Syndrome-Implications for Future Management.

Authors:  Christopher M Dwyer; Linda Thien-Trang Nguyen; Luke M Healy; Ranjan Dutta; Samuel Ludwin; Jack Antel; Michele D Binder; Trevor J Kilpatrick
Journal:  Front Neurol       Date:  2020-08-28       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.